News & Events

  • September 24, 2013

    Neurotrope, Inc. announced the closing of their reverse merger in the amount of $21,900,000.  EG&S acted as counsel to Neurotrope.

  • September 23, 2013

    Bill Peterson joins EG&S as a Member in its Broker-Dealer Regulation and Corporate and Securities Practices.

    Click here to read his announcement

  • September 23, 2013

    Agenus Inc. announced the closing of their Registered Direct offering in the amount of $10,000,000.  EG&S acted as counsel to the Placement Agent.

  • September 23, 2013

    Oxigene Inc. announced the closing of their PIPE offering in the amount of $5,800,000.  EG&S acted as counsel to the Placement Agent.

  • September 19, 2013

    MicroVision, Inc. announced the closing of their Registered Direct offering in the amount of $564,000.  EG&S acted as counsel to the Placement Agent.

  • September 18, 2013

    Oncosec Medical Inc. announced the closing of their Registered Direct offering in the amount of $11,948,000.  EG&S acted as counsel to the Placement Agent.

  • September 10, 2013

    Neuralstem, Inc. announced the closing of their Registered Direct offering in the amount of $4,556,000.  EG&S acted as counsel to the Placement Agent.

  • September 09, 2013

    Future Health of America announced the closing of their PIPE offering in the amount of $1,010,000.  EG&S acted as counsel to the Investor.

  • September 06, 2013

    Amarantus Bioscience Holdings Inc. announced the closing of their PIPE offering in the amount of $5,555,550.  EG&S acted as counsel to the Investor.

  • August 30, 2013

    Thing Daemon, Inc., which owns and operates the social commerce website Fancy, successfully raised $60 million through a private placement of its Series C Preferred Stock to accredited investors. EG&S acted as counsel to Thing Daemon, Inc.

  • August 29, 2013

    Quadrant 4 Systems Corporation announced the closing of their PIPE offering in the amount of $1,128,107.  EG&S acted as counsel to the Investor.

  • August 29, 2013

    Boldface Group, Inc. announced the closing of their PIPE offering in the amount of $616,000.  EG&S acted as counsel to the Investor.

  • August 21, 2013

    Genspera Inc. announced the closing of their PIPE offering in the amount of $5,000,032.  EG&S acted as counsel to the Placement Agent.

  • August 21, 2013

    Mandalay Digital Group, Inc. announced the closing of their Underwritten offering in the amount of $11,220,000.  EG&S acted as counsel to the Placement Agent.

  • August 20, 2013

    China Commercial Credit, Inc. (NASDAQ: CCCR) announced it has closed its initial public offering in the amount of $8,905,000. EG&S acted as counsel to China Commercial Credit.

  • August 19, 2013

    Amarantus Bioscience Holdings Inc. announced the closing of their PIPE offering in the amount of $652,683.  EG&S acted as counsel to the Investor.

  • August 15, 2013

    Quinpario Acquisition Corp. (QPACU), announced the closing of its initial public offering in the amount of $172,500,000. EG&S LLP acted as counsel to Quinpario.

  • August 13, 2013

    Northwest Biotherapeutics Inc. announced the closing of their Registered Direct offering in the amount of $13,502,501.  EG&S acted as counsel to the Investor.

  • August 13, 2013

    OCZ Technology Group, Inc. announced the closing of their PIPE offering in the amount of $13,098,500.  EG&S acted as counsel to the Issuer.

  • August 09, 2013

    Superconductor Technologies Inc. announced the closing of their Underwritten offering in the amount of $12,000,000.  EG&S acted as counsel to the Underwriter.

  • August 06, 2013

    ParkerVision, Inc. announced the closing of their PIPE offering in the amount of $13,989,976.  EG&S acted as counsel to the Placement Agent.

  • July 30, 2013

    Aeterna Zentaris, Inc. announced the closing of their Registered Direct offering in the amount of $7,800,000.  EG&S acted as counsel to the Placement Agent.

  • July 29, 2013

    Box Ships Inc. (NYSE:TEU) announced the closing of a public offering of 558,333 shares of its newly designated 9.00% Series C Cumulative Redeemable Perpetual Preferred Stock for gross proceeds of $13.4 million. EG&S acted as counsel to the underwriters of the public offering.
     

  • July 23, 2013

    Oxygen Biotherapeutics Inc. announced the closing of their Registered Direct offering in the amount of $5,369,000.  EG&S acted as counsel to the Placement Agent.

  • July 19, 2013

    Netlist, Inc. announced the closing of their Registered Direct offering in the amount of $1,000,000.  EG&S acted as counsel to the Investor.